Bio-Connect

Anti-PCSK9 [508.20.33b (Fab33)], Mouse IgG2a, kappa

Research Use Only
AB02938-2.0-BT
Absolute Antibody
ApplicationsFunctional Assay, ELISA, Neutralisation/Blocking, Other Application
Product group Antibodies
ReactivityHuman, Monkey, Mouse, Primate, Rat
TargetPCSK9
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Absolute Antibody
  • Product Name
    Anti-PCSK9 [508.20.33b (Fab33)], Mouse IgG2a, kappa
  • Delivery Days Customer
    9
  • Antibody Specificity
    This antibody binds human PCSK9. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a serine protease enzyme encoded by the PCSK9 gene in humans and it plays a role in regulation of circulating cholesterol. It is associated with autosomal dominant h
  • Application Supplier Note
    The binding affinity of this antibody towards PCSK9 protein from human, murine, rhesus, and cynomolgus monkey was done using surface plasmon resonance. This antibody was found to inhibit binding of PCSK9 to LDLR in a competition binding ELISA. This antibody plays a role in effective prevention of LDLR downregulation in HepG2 cells in vitro. When administered in vivo, this antibody prevented LDLR downregulation in mouse liver. This antibody showed a reduction in total serum cholesterol levels in mice when a single dose of 10 mg/kg was administered. It was also found that a combination of this antibody and statin results in a greater reduction in total cholesterol level compared to anti-PCSK9 antibody alone or statin alone treatments (US9266961). A randomized, double-blind, placebo-controlled, single and multiple dose study was conducted to evaluate, primarily, the safety and tolerability of single and multiple (four weekly) doses of reformatted IgG1 version of this antibody when administered by subcutaneous (SC) injection to healthy volunteers with elevated serum low-density lipoprotein cholesterol (LDL-c) concentration. It was found that there were no serious or severe adverse events, no discontinuations for adverse events, and no dose-limiting toxicities (US9266961).
  • Applications
    Functional Assay, ELISA, Neutralisation/Blocking, Other Application
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    508.20.33b (Fab33)
  • Gene ID255738
  • Target name
    PCSK9
  • Target description
    proprotein convertase subtilisin/kexin type 9
  • Target synonyms
    convertase subtilisin/kexin type 9 preproprotein; FH3; FHCL3; HCHOLA3; LDLCQ1; NARC1; NARC-1; neural apoptosis regulated convertase 1; PC9; proprotein convertase subtilisin/kexin type 9; subtilisin/kexin-like protease PC9
  • Host
    Mouse
  • Isotype
    IgG2a
  • Protein IDQ8NBP7
  • Protein Name
    Proprotein convertase subtilisin/kexin type 9
  • Scientific Description
    This is a chimeric mouse IgG2a antibody made using the variable domain sequences of the original human IgG1 format. It was created to improve compatibility with existing reagents, assays, and techniques.
  • Reactivity
    Human, Monkey, Mouse, Primate, Rat
  • Storage Instruction
    -20°C,2°C to 8°C
  • UNSPSC
    12352203